Benign Prostatic Hyperplasia (BPH), the non-cancerous enlargement of the prostate gland, is common in aging men and leads to bothersome urinary symptoms due to pressure on the urethra. These symptoms often include a frequent and urgent need to urinate (especially at night), a weak or interrupted urine stream, difficulty starting urination, and a feeling of incomplete bladder emptying. Initial management typically involves lifestyle modifications and prescription medications (like alpha-blockers or 5-alpha-reductase inhibitors) to relax the prostate or shrink it. If these are ineffective, a range of surgical and minimally invasive procedures are available, including transurethral resection of the prostate (TURP)—considered the gold standard—as well as newer laser therapies (HoLEP, GreenLight) and minimally invasive options like Rezūm water vapor therapy, which offer faster recovery with less invasiveness. Costs vary widely from the ongoing expense of medications to the significant one-time cost of surgery, which is influenced by the procedure type, hospital fees, and anesthesia. For hospital care, seeking a urology department with a high volume of BPH procedures is recommended, as surgeons at such centers have extensive experience with the full spectrum of treatment options and can help patients choose the best approach for their specific case and symptoms.